MediWound Ltd. (MDWD)

MediWound Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-23.88	-30.22	-6.72	-19.6
Depreciation & Amortization	1.86	1.48	1.3	1.27
Stock-Based Compensation	3.11	3.14	1.94	1.95
Other Adjustments	-1.98	10.71	-9.33	11.74
Change in Receivables	4.88	-1.02	4.76	-7.22
Changes in Inventories	-1.36	0.19	-0.91	-0.72
Changes in Accounts Payable	2.35	0.41	-0.59	0.41
Changes in Accrued Expenses	-1.1	0.52	-0.93	0.28
Changes in Unearned Revenue	-	1.18	-	-
Operating Cash Flow	-16.12	-13.62	-10.47	-11.89
Capital Expenditures	-5.51	-6.27	-6.46	-0.56
Purchases of Investments	-14.04	-4.38	-29.8	-
Other Investing Activities	1.59	2.25	1.95	0.07
Investing Cash Flow	-17.95	-8.4	-34.32	-0.48
Issuance of Common Stock	31.05	23.38	24.91	38.39
Net Common Stock Issued (Repurchased)	31.05	23.38	24.91	38.39
Other Financing Activities	-1.43	-3.98	-1.99	-2.63
Financing Cash Flow	29.62	19.39	22.92	35.76
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.1	-0.08	-0.16	-0.55
Net Cash Flow	-4.36	-2.71	-22.03	22.85
Free Cash Flow	-21.63	-19.9	-16.93	-12.44
FCF Margin	-127.52%	-98.39%	-90.60%	-46.95%
Free Cash Flow Per Share	-1.90	-2.00	-1.88	-2.49
Levered Free Cash Flow	-27.63	-32.72	-14.31	-18.91
Unlevered Free Cash Flow	-28.84	-21.86	-22.45	-7.62

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q